Related references
Note: Only part of the references are listed.Omadacycline for Community-Acquired Bacterial Pneumonia
Roman Stets et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza
Timothy M. Uyeki et al.
CLINICAL INFECTIOUS DISEASES (2019)
Systematic Review and Meta-analysis of the Efficacy of Short-Course Antibiotic Treatments for Community-Acquired Pneumonia in Adults
Giannoula S. Tansarli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
The Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta-analysis With Antimicrobial Stewardship Implications
Diane M. Parente et al.
CLINICAL INFECTIOUS DISEASES (2018)
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients
Marcos Restrepo et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Low procalcitonin, community acquired pneumonia, and antibiotic therapy
Ishan S. Kamat et al.
LANCET INFECTIOUS DISEASES (2018)
Corticosteroids in Patients Hospitalized With Community-Acquired Pneumonia: Systematic Review and Individual Patient Data Metaanalysis
Matthias Briel et al.
CLINICAL INFECTIOUS DISEASES (2018)
Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia
Diego Viasus et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Variation in Empiric Coverage Versus Detection of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in Hospitalizations for Community-Onset Pneumonia Across 128 US Veterans Affairs Medical Centers
Barbara E. Jones et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2017)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Andrew Rhodes et al.
INTENSIVE CARE MEDICINE (2017)
A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia
Yang Liu et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2017)
The respiratory threat posed by multidrug resistant Gram-negative bacteria
Ana Rodrigo-Troyano et al.
RESPIROLOGY (2017)
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
Akbar K. Waljee et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
Akbar K. Waljee et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Collaborative approach of individual participant data of prospective studies of de-escalation in non-immunosuppressed critically ill patients with sepsis
Antonio Gutierrez-Pizarraya et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2017)
Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
Wesley H. Self et al.
CLINICAL INFECTIOUS DISEASES (2017)
Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis
K. Z. Vardakas et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis
Sudhir Venkatesan et al.
CLINICAL INFECTIOUS DISEASES (2017)
Predictors of Pseudomonas and methicillin-resistant Staphylococcus aureus in hospitalized patients with healthcare-associated pneumonia
Mark L. Metersky et al.
RESPIROLOGY (2016)
Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score
Brandon J. Webb et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa
Catia Cilloniz et al.
CHEST (2016)
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
Andre C. Kalil et al.
CLINICAL INFECTIOUS DISEASES (2016)
Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality
Elisa Costantini et al.
INTERNAL AND EMERGENCY MEDICINE (2016)
Antibiotic Therapy for Adults Hospitalized With Community-Acquired Pneumonia A Systematic Review
Jonathan S. Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis The HYPRESS Randomized Clinical Trial
Didier Keh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Health care-associated pneumonia in the intensive care unit: Guideline-concordant antibiotics and outcomes
Russell T. Attridge et al.
JOURNAL OF CRITICAL CARE (2016)
De-escalation versus continuation of empirical antimicrobial therapy in community-acquired pneumonia
Hayato Yamana et al.
JOURNAL OF INFECTION (2016)
Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis
Alejandro H. Rodriguez et al.
JOURNAL OF INFECTION (2016)
Selection of empirical antibiotics for health care-associated pneumonia via integration of pneumonia severity index and risk factors of drug-resistant pathogens
Ping-Huai Wang et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2016)
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study
Stefano Aliberti et al.
LANCET INFECTIOUS DISEASES (2016)
Beta-lactam plus macrolides or beta-lactam alone for community-acquired pneumonia: A systematic review and meta-analysis
Nobuyuki Horita et al.
RESPIROLOGY (2016)
Duration of Antibiotic Treatment in Community-Acquired Pneumonia A Multicenter Randomized Clinical Trial
Ane Uranga et al.
JAMA INTERNAL MEDICINE (2016)
Vital Signs: Deficiencies in Environmental Control Identified in Outbreaks of Legionnaires' Disease - North America, 2000-2014
Laurel E. Garrison et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2016)
Predictors and Implications of Early Clinical Stability in Patients Hospitalized for Moderately Severe Community-Acquired Pneumonia
Nicolas Garin et al.
PLOS ONE (2016)
Use of Tracheal Aspirate Culture in Newly Intubated Patients with Community-Onset Pneumonia
Lindsay M. McCauley et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Impact of an Electronic Clinical Decision Support Tool for Emergency Department Patients With Pneumonia
Nathan C. Dean et al.
ANNALS OF EMERGENCY MEDICINE (2015)
Corticosteroid Therapy for Patients Hospitalized With Community Acquired Pneumonia A Systematic Review and Meta-analysis
Reed A. C. Siemieniuk et al.
ANNALS OF INTERNAL MEDICINE (2015)
Trends in Antibiotic Use and Nosocomial Pathogens in Hospitalized Veterans With Pneumonia at 128 Medical Centers, 2006-2010
Barbara E. Jones et al.
CLINICAL INFECTIOUS DISEASES (2015)
Is post-pneumonia chest X-ray for lung malignancy useful? Results of an audit of current practice
C. Macdonald et al.
INTERNAL MEDICINE JOURNAL (2015)
Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis
Ayelet Raz-Pasteur et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Effect of Corticosteroids on Treatmmt Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory Response A Randomized Clinical Trial
Antoni Torres et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia
Michael B. Rothberg et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Microbiology and outcomes of community acquired pneumonia in non cystic-fibrosis bronchiectasis patients
Eva Polverino et al.
JOURNAL OF INFECTION (2015)
Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia
Kazuhiro Kamata et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2015)
Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial
Claudine Angela Blum et al.
LANCET (2015)
Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials
Joanna Dobson et al.
LANCET (2015)
Antibiotic Treatment Strategies for Community-Acquired Pneumonia in Adults
Douwe F. Postma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Individualizing Risk of Multidrug-Resistant Pathogens in Community-Onset Pneumonia
Marco Falcone et al.
PLOS ONE (2015)
Predicting risk of drug-resistant organisms in pneumonia: Moving beyond the HCAP model
Brandon J. Webb et al.
RESPIRATORY MEDICINE (2015)
Adjunctive Systemic Corticosteroids for Hospitalized Community-Acquired Pneumonia: Systematic Review and Meta-Analysis 2015 Update
Nobuyuki Horita et al.
SCIENTIFIC REPORTS (2015)
Active Bacterial Core Surveillance for Legionellosis — United States, 2011–2013
Kathleen L. Dooling et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2015)
Risk Factors Associated with Potentially Antibiotic-Resistant Pathogens in Community-Acquired Pneumonia
Elena Prina et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)
Efficacy and safety of glucocorticoids in the treatment of community-acquired pneumonia: A meta-analysis of randomized controlled trials
Li-ping Chen et al.
WORLD JOURNAL OF EMERGENCY MEDICINE (2015)
Outcome of Recommendations for Radiographic Follow-Up of Pneumonia on Outpatient Chest Radiography
Brent P. Little et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2014)
Predictive Value of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab PCR Assay for MRSA Pneumonia
Benjamin Dangerfield et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Relationship between Time to Clinical Response and Outcomes among Pneumonia Outcomes Research Team (PORT) Risk Class III and IV Hospitalized Patients with Community-Acquired Pneumonia Who Received Ceftriaxone and Azithromycin
Evan Zasowski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Epidemiology and Predictors of Multidrug-Resistant Community-Acquired and Health Care-Associated Pneumonia
Alan E. Gross et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Patients presenting to the hospital with MRSA pneumonia: differentiating characteristics and outcomes with empiric treatment
Emi Minejima et al.
BMC INFECTIOUS DISEASES (2014)
Healthcare-Associated Pneumonia Does Not Accurately Identify Potentially Resistant Pathogens: A Systematic Review and Meta-Analysis
James D. Chalmers et al.
CLINICAL INFECTIOUS DISEASES (2014)
Macrolides and Mortality in Critically Ill Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis
Wendy I. Sligl et al.
CRITICAL CARE MEDICINE (2014)
De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial
Marc Leone et al.
INTENSIVE CARE MEDICINE (2014)
A comparison between time to clinical stability in community-acquired aspiration pneumonia and community-acquired pneumonia
Philippe Jaoude et al.
INTERNAL AND EMERGENCY MEDICINE (2014)
Impact of guideline-concordant microbiological testing on outcomes of pneumonia
Hironori Uematsu et al.
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE (2014)
Effect of antibiotic streamlining on patient outcome in pneumococcal bacteraemia
Amelieke J. H. Cremers et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis
Wei Nie et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Serum Procalcitonin Level, Viral Polymerase Chain Reaction Analysis, and Lower Respiratory Tract Infection
Daniel M. Musher et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Preventing and Controlling Influenza with Available Interventions
Timothy M. Uyeki
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Community-Acquired Pneumonia
Daniel M. Musher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
β-Lactam Monotherapy vs β-Lactam-Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia A Randomized Noninferiority Trial
Nicolas Garin et al.
JAMA INTERNAL MEDICINE (2014)
Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis
Roman Pfister et al.
CRITICAL CARE (2014)
Risk Factors for Drug-Resistant Pathogens in Community-acquired and Healthcare-associated Pneumonia
Yuichiro Shindo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Outcomes of Health Care-Associated Pneumonia Empirically Treated with Guideline-Concordant Regimens Versus Community-Acquired Pneumonia Guideline-Concordant Regimens for Patients Admitted to Acute Care Wards from Home
Jenny I. Chen et al.
ANNALS OF PHARMACOTHERAPY (2013)
Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia
David Oldach et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia
Won Jai Jung et al.
BMC INFECTIOUS DISEASES (2013)
A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia
Andrew F. Shorr et al.
BMC INFECTIOUS DISEASES (2013)
High-Dose Levofloxacin in Community-Acquired Pneumonia
Jin Hwa Lee et al.
CLINICAL DRUG INVESTIGATION (2013)
Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia
D. A. Wooten et al.
RESPIRATORY MEDICINE (2013)
Healthcare-associated pneumonia: A US disease or relevant to the Asia Pacific, too?
Claudia C. Dobler et al.
RESPIROLOGY (2013)
Adjuvant role of corticosteroids in the treatment of community-acquired pneumonia
Ramadan M. Nafae et al.
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS (2013)
Outcomes of Early, Late, and No Admission to the Intensive Care Unit for Patients Hospitalized with Community-acquired Pneumonia
Bertrand Renaud et al.
ACADEMIC EMERGENCY MEDICINE (2012)
Cethromycin versus Clarithromycin for Community-Acquired Pneumonia: Comparative Efficacy and Safety Outcomes from Two Double-Blinded, Randomized, Parallel-Group, Multicenter, Multinational Noninferiority Studies
Marci L. English et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1) pdm09
Janice K. Louie et al.
CLINICAL INFECTIOUS DISEASES (2012)
THE EFFECTS OF INCORPORATING A PNEUMONIA SEVERITY INDEX INTO THE ADMISSION PROTOCOL FOR COMMUNITY-ACQUIRED PNEUMONIA
Sion Jo et al.
JOURNAL OF EMERGENCY MEDICINE (2012)
Myocardial Injury and Bacterial Pneumonia Contribute to the Pathogenesis of Fatal Influenza B Virus Infection
Christopher D. Paddock et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Clinical and Economic Burden of Community-Acquired Pneumonia in the Medicare Fee-for-Service Population
Holly Yu et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2012)
Adding fuel to the flames? It is time to leave HCAP
Santiago Ewig et al.
RESPIRATORY MEDICINE (2012)
Relationships among initial hospital triage, disease progression and mortality in community-acquired pneumonia
Samuel M. Brown et al.
RESPIROLOGY (2012)
Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis
Christophe Marti et al.
CRITICAL CARE (2012)
Incidence, Correlates, and Chest Radiographic Yield of New Lung Cancer Diagnosis in 3398 Patients With Pneumonia
Karen L. Tang et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital
Ji Ye Jung et al.
BMC INFECTIOUS DISEASES (2011)
CURB-65 Pneumonia Severity Assessment Adapted for Electronic Decision Support
Barbara E. Jones et al.
CHEST (2011)
Validation of the Infectious Diseases Society of America/American Thoratic Society Minor Criteria for Intensive Care Unit Admission in Community-Acquired Pneumonia Patients Without Major Criteria or Contraindications to Intensive Care Unit Care
James D. Chalmers et al.
CLINICAL INFECTIOUS DISEASES (2011)
Guideline-concordant therapy and outcomes in healthcare-associated pneumonia
R. T. Attridge et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis
James D. Chalmers et al.
INTENSIVE CARE MEDICINE (2011)
Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia
Cynthia Grenier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
GRADE guidelines: 2. Framing the question and deciding on important outcomes
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Diagnosis of Pulmonary Malignancy after Hospitalization for Pneumonia
Eric M. Mortensen et al.
AMERICAN JOURNAL OF MEDICINE (2010)
2009 Pandemic Influenza A (H1N1) Pathology and Pathogenesis of 100 Fatal Cases in the United States
Wun-Ju Shieh et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Efficacy and Safety of Nemonoxacin versus Levofloxacin for Community-Acquired Pneumonia
Dirkie J. J. van Rensburg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Late Admission to the ICU in Patients With Community-Acquired Pneumonia Is Associated With Higher Mortality
Marcos I. Restrepo et al.
CHEST (2010)
Fatalities Associated with the 2009 H1N1 Influenza A Virus in New York City
Ellen H. Lee et al.
CLINICAL INFECTIOUS DISEASES (2010)
Invasive Group A Streptococcal Infection Concurrent with 2009 H1N1 Influenza
Cynthia Jean et al.
CLINICAL INFECTIOUS DISEASES (2010)
Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors
H. von Baum et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
The impact of a delay in intensive care unit admission for community-acquired pneumonia
J. Phua et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States
Alicia M. Siston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Doxycycline vs. levofloxacin in the treatment of community-acquired pneumonia
R. Mokabberi et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2010)
Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia
M. Falguera et al.
THORAX (2010)
Outcomes of adults hospitalised with severe influenza
N. Lee et al.
THORAX (2010)
De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit
Jerome Morel et al.
CRITICAL CARE (2010)
Severe Community-Acquired Pneumonia: Validation of the Infectious Diseases Society of America/American Thoracic Society Guidelines to Predict an Intensive Care Unit Admission
Adamantia Liapikou et al.
CLINICAL INFECTIOUS DISEASES (2009)
Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia
Samuel M. Brown et al.
CRITICAL CARE MEDICINE (2009)
Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia
J. Phua et al.
THORAX (2009)
Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP - Results from the German competence network CAPNETZ
Stefan Krueger et al.
RESPIRATORY RESEARCH (2009)
SMART-COP: A tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia
Patrick G. P. Charles et al.
CLINICAL INFECTIOUS DISEASES (2008)
Short- versus long-course antibacterial therapy for community-acquired pneumonia - A meta-analysis
George Dimopoulos et al.
DRUGS (2008)
Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis
N. Maimon et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: an open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days
R. Paris et al.
JOURNAL OF CHEMOTHERAPY (2008)
Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada
Allison McGeer et al.
CLINICAL INFECTIOUS DISEASES (2007)
Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease
Ricard Pifarre et al.
RESPIRATORY MEDICINE (2007)
Efficacy of short-course antibiotic regimens for community-acquired pneumonia: A meta-analysis
Jonathan Z. Li et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Selective use of blood cultures in emergency department pneumonia patients
Ronald S. Benenson et al.
JOURNAL OF EMERGENCY MEDICINE (2007)
Routine use of the pneumonia severity index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: A multicenter, prospective, observational, controlled cohort study
Bertrand Renaud et al.
CLINICAL INFECTIOUS DISEASES (2007)
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A. Mandell et al.
CLINICAL INFECTIOUS DISEASES (2007)
Macrolide resistance in bacteremic pneumococcal disease: Implications for patient management
N. Daneman et al.
CLINICAL INFECTIOUS DISEASES (2006)
Factors associated with the hospitalization of low-risk patients with community-acquired pneumonia in a cluster-randomized trial
Jose Labarere et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2006)
Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia a Randomized trial
Miriam Christ-Crain et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study
Rachida el Moussaoui et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season
Jeffrey C. Hageman et al.
EMERGING INFECTIOUS DISEASES (2006)
Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae
B Siquier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Effect of increasing the intensity of implementing pneumonia guidelines - A randomized, controlled trial
DM Yealy et al.
ANNALS OF INTERNAL MEDICINE (2005)
Low-risk patients admitted with community-acquired pneumonia
TJ Marrie et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Epidemiology and outcomes of health-care-associated pneumonia - Results from a large US database of culture-positive pneumonia
MH Kollef et al.
CHEST (2005)
Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired pneumonia in adults
J D'Ignazio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Home management of mild to moderately severe community-acquired pneumonia: a randomised controlled trial
DA Richards et al.
MEDICAL JOURNAL OF AUSTRALIA (2005)
Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study
MM van der Eerden et al.
THORAX (2005)
Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia
D Aujesky et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
[Anonymous]
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Outpatient care compared with hospitalization for community-acquired pneumonia -: A randomized trial in low-risk patients
J Carratalà et al.
ANNALS OF INTERNAL MEDICINE (2005)
Hydrocortisone infusion for severe community-acquired pneumonia - A preliminary randomized study
M Confalonieri et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Predicting bacteremia in patients with community-acquired pneumonia
ML Metersky et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Multicenter, open-label, randomized study to compare the safety and efficacy of levofloxacin versus ceftriaxone sodium and erythromycin followed by clarithromycin and amoxicillin-clavulanate in the treatment of serious community-acquired pneumonia in adults
C Fogarty et al.
CLINICAL INFECTIOUS DISEASES (2004)
Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system
E García-Vázquez et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia
G Tellier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Reaching stability in community-acquired pneumonia:: The effects of the severity of disease, treatment, and the characteristics of patients
R Menéndez et al.
CLINICAL INFECTIOUS DISEASES (2004)
Diagnostic value of microscopic examination of gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia
DM Musher et al.
CLINICAL INFECTIOUS DISEASES (2004)
Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults
LM Dunbar et al.
CLINICAL THERAPEUTICS (2004)
Risk factors of treatment failure in community acquired pneumonia:: implications for disease outcome
R Menéndez et al.
THORAX (2004)
Treatment costs of community-acquired pneumonia in an employed population
GL Colice et al.
CHEST (2004)
High-dose, short-course Levofloxacin for community-acquired pneumonia: A new treatment paradigm
LM Dunbar et al.
CLINICAL INFECTIOUS DISEASES (2003)
Microbiology of severe aspiration pneumonia in institutionalized elderly
AA El-Solh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study
WS Lim et al.
THORAX (2003)
The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia - A prospective observational study
SG Campbell et al.
CHEST (2003)
Comparison of clarithromycin and amoxicillin/clavulanic acid for community-acquired pneumonia in an era of drug-resistant Streptococcus pneumoniae
P Bonvehi et al.
CLINICAL DRUG INVESTIGATION (2003)
Limited value of routine microbiological diagnostics in patients hospitalized for community-acquired pneumonia
C Lidman et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2002)
Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia
L Hagberg et al.
INFECTION (2002)
A comparison of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of community-acquired pneumonia: A multicenter, prospective, randomized, investigator-blinded, parallel-group study
CM Fogarty et al.
CLINICAL THERAPEUTICS (2002)
Factors associated with unknown aetiology in patients with community-acquired pneumonia
S Ewig et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa -: Incidence, risk, and prognosis
F Arancibia et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae
JR Lonks et al.
CLINICAL INFECTIOUS DISEASES (2002)
A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia
E Frank et al.
CLINICAL THERAPEUTICS (2002)
A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia
MH Gotfried et al.
CLINICAL THERAPEUTICS (2002)
Applying sputum as a diagnostic tool in pneumonia -: Limited yield, minimal impact on treatment decisions
S Ewig et al.
CHEST (2002)
Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals
J Dedier et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Primary care: Aspiration pneumonitis and aspiration pneumonia.
PE Marik
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures
GW Waterer et al.
RESPIRATORY MEDICINE (2001)
Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults
P Petitpretz et al.
CHEST (2001)
Prospective study of the usefulness of sputum gram stain in the initial approach to community-acquired pneumonia requiring hospitalization
B Rosón et al.
CLINICAL INFECTIOUS DISEASES (2000)
Antimicrobial treatment failures in patients with community-acquired pneumonia - Causes and prognostic implications
F Arancibia et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
A controlled trial of a critical pathway for treatment of community-acquired pneumonia
TJ Marrie et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
